Authors:
Han, GZ
Foster, BA
Mistry, S
Buchanan, G
Harris, JM
Tilley, WD
Greenberg, NM
Citation: Gz. Han et al., Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer, J BIOL CHEM, 276(14), 2001, pp. 11204-11213
Authors:
Shariat, SF
Desai, S
Song, WT
Khan, T
Zhao, J
Nguyen, C
Foster, BA
Greenberg, N
Spencer, DM
Slawin, KM
Citation: Sf. Shariat et al., Adenovirus-mediated transfer of inducible caspases: A novel "death switch"gene therapeutic approach to prostate cancer, CANCER RES, 61(6), 2001, pp. 2562-2571
Authors:
Hurwitz, AA
Foster, BA
Kwon, ED
Truong, T
Choi, EM
Greenberg, NM
Burg, MB
Allison, JP
Citation: Aa. Hurwitz et al., Combination immunotherapy of primary prostate cancer in a transgenic mousemodel using CTLA-4 blockade, CANCER RES, 60(9), 2000, pp. 2444-2448
Citation: Ba. Foster et al., Characterization of the FGF axis and identification of a novel FGFR1iiic isoform during prostate cancer progression in the TRAMP model, PROSTATE C, 2(2), 1999, pp. 76-82
Authors:
Ghosh, PM
Ghosh-Choudhury, N
Moyer, ML
Mott, GE
Thomas, CA
Foster, BA
Greenberg, NM
Kreisberg, JI
Citation: Pm. Ghosh et al., Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line, ONCOGENE, 18(28), 1999, pp. 4120-4130
Authors:
Kwon, ED
Foster, BA
Hurwitz, AA
Madias, C
Allison, JP
Greenberg, NM
Burg, MB
Citation: Ed. Kwon et al., Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy, P NAS US, 96(26), 1999, pp. 15074-15079
Citation: Ba. Foster et Gr. Cunha, Efficacy of various natural and synthetic androgens to induce ductal branching morphogenesis in the developing anterior rat prostate, ENDOCRINOL, 140(1), 1999, pp. 318-328
Authors:
Kaplan, PJ
Mohan, S
Cohen, P
Foster, BA
Greenberg, NM
Citation: Pj. Kaplan et al., The insulin-like growth factor axis and prostate cancer: Lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model, CANCER RES, 59(9), 1999, pp. 2203-2209